Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.94)
# 112
Out of 4,534 analysts
1193
Total ratings
53.5%
Success rate
31.2%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.05 | +719.67% | 27 | Jul 20, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $55 | $33.50 | +64.18% | 26 | Jul 20, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $70 | $11.67 | +499.83% | 60 | Jul 20, 2026 | |
| ATAI AtaiBeckley | Downgraded: Hold | $25 → $7.5 | $7.19 | +4.31% | 56 | Jul 20, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $50 | $5.28 | +846.97% | 21 | Jul 14, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $470 → $485 | $272.67 | +77.87% | 75 | Jul 13, 2026 | |
| ONCY Oncolytics Biotech | Reiterated: Buy | $10 | $0.85 | +1,076.47% | 50 | Jul 13, 2026 | |
| AIM: FARN Faron Pharmaceuticals Oy | Reiterated: Buy | 1,000p | 39p | +2,434.85% | 26 | Jul 13, 2026 | |
| MRKR Marker Therapeutics | Reiterated: Buy | $10 | $1.28 | +681.25% | 7 | Jul 9, 2026 | |
| DTIL Precision BioSciences | Reiterated: Buy | $60 | $7.36 | +715.22% | 65 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $70 | $7.11 | +884.53% | 43 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.6853 | +1,359.21% | 38 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $26.33 | +203.84% | 27 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $71.65 | +39.57% | 69 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $80 | $39.70 | +101.51% | 61 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $4.18 | +976.56% | 11 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $2 | $0.141 | +1,318.44% | 49 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $74.61 | +94.34% | 14 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $25.90 | +93.05% | 20 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $42.80 | +63.55% | 44 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $28.19 | +112.84% | 1 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $11.98 | +192.15% | 1 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $10.49 | +614.97% | 42 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $33.55 | +78.84% | 9 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.07 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $2.81 | +611.74% | 48 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $25.06 | +99.52% | 14 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.23 | +116.68% | 66 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $34.05 | +193.69% | 52 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $27.53 | +136.11% | 39 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $10 | $1.18 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $360 | $15.04 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.97 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.045 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 6p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €33.00 | €3.49 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $47.42 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $130 | $13.16 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $10.59 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $3.85 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $21.28 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $108.48 | n/a | 1 | Dec 23, 2014 |
Voyager Therapeutics
Jul 20, 2026
Reiterated: Buy
Price Target: $25
Current: $3.05
Upside: +719.67%
Harmony Biosciences Holdings
Jul 20, 2026
Reiterated: Buy
Price Target: $55
Current: $33.50
Upside: +64.18%
COMPASS Pathways
Jul 20, 2026
Maintained: Buy
Price Target: $70
Current: $11.67
Upside: +499.83%
AtaiBeckley
Jul 20, 2026
Downgraded: Hold
Price Target: $25 → $7.5
Current: $7.19
Upside: +4.31%
Aligos Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $50
Current: $5.28
Upside: +846.97%
Alnylam Pharmaceuticals
Jul 13, 2026
Reiterated: Buy
Price Target: $470 → $485
Current: $272.67
Upside: +77.87%
Oncolytics Biotech
Jul 13, 2026
Reiterated: Buy
Price Target: $10
Current: $0.85
Upside: +1,076.47%
Faron Pharmaceuticals Oy
Jul 13, 2026
Reiterated: Buy
Price Target: 1,000p
Current: 39p
Upside: +2,434.85%
Marker Therapeutics
Jul 9, 2026
Reiterated: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Precision BioSciences
Jul 9, 2026
Reiterated: Buy
Price Target: $60
Current: $7.36
Upside: +715.22%
Jul 9, 2026
Reiterated: Buy
Price Target: $95 → $70
Current: $7.11
Upside: +884.53%
Jul 8, 2026
Reiterated: Buy
Price Target: $10
Current: $0.6853
Upside: +1,359.21%
Jul 7, 2026
Reiterated: Buy
Price Target: $80
Current: $26.33
Upside: +203.84%
Jul 6, 2026
Reiterated: Buy
Price Target: $100
Current: $71.65
Upside: +39.57%
Jun 29, 2026
Reiterated: Buy
Price Target: $50 → $80
Current: $39.70
Upside: +101.51%
Jun 25, 2026
Reiterated: Buy
Price Target: $45
Current: $4.18
Upside: +976.56%
Jun 25, 2026
Reiterated: Buy
Price Target: $5 → $2
Current: $0.141
Upside: +1,318.44%
Jun 25, 2026
Reiterated: Buy
Price Target: $145
Current: $74.61
Upside: +94.34%
Jun 25, 2026
Reiterated: Buy
Price Target: $50
Current: $25.90
Upside: +93.05%
Jun 23, 2026
Reiterated: Buy
Price Target: $70
Current: $42.80
Upside: +63.55%
Jun 23, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $28.19
Upside: +112.84%
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $11.98
Upside: +192.15%
Jun 17, 2026
Reiterated: Buy
Price Target: $75
Current: $10.49
Upside: +614.97%
Jun 16, 2026
Reiterated: Buy
Price Target: $60
Current: $33.55
Upside: +78.84%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.07
Upside: -
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $2.81
Upside: +611.74%
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $25.06
Upside: +99.52%
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $9.23
Upside: +116.68%
Jun 3, 2026
Reiterated: Buy
Price Target: $100
Current: $34.05
Upside: +193.69%
May 19, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $27.53
Upside: +136.11%
Apr 2, 2025
Maintained: Buy
Price Target: $25 → $10
Current: $1.18
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $20 → $360
Current: $15.04
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $11.97
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.045
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 6p
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: €33.00
Current: €3.49
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $47.42
Upside: n/a
Sep 18, 2019
Maintained: Buy
Price Target: $120 → $130
Current: $13.16
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $10.59
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $3.85
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $21.28
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $108.48
Upside: n/a